Navigation Links
AcelRx Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
Date:11/26/2013

ant from the U.S. Army Medical Research and Materiel Command.  The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development.  For additional information about AcelRx's clinical programs, please visit www.acelrx.com.

Forward Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements related to planned or anticipated future clinical development of AcelRx Pharmaceuticals' product candidates, and the therapeutic potential of AcelRx Pharmaceuticals' product candidates.  These forward-looking statements are based on AcelRx Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties.  AcelRx Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: the success, cost and timing of AcelRx Pharmaceuticals' product development; the market potential for its product candidates; and other risks detailed in the "Risk Factors" and elsewhere in AcelRx Pharmaceuticals' U.S. Securities and Exchange Commission filings, including its Quarterly Report on Form 10-Q filed with the SEC on November 5, 2013.  AcelRx Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

(Logo: http://photos.prnewswire.com/prnh/20130226/MM67303LOGO)


'/>"/>
SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
2. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
3. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
7. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
8. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
9. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... PAUL, Minn. , July 29, 2014  EnteroMedics ... medical devices using neuroblocking technology to treat obesity, metabolic ... will host a conference call on Thursday, August 7, ... results for the second quarter ended June 30, 2014 ... Call Details The second quarter conference call ...
(Date:7/29/2014)... New high priced hepatitis C drugs will increase federal ... to $5.8 billion next year, according to a new ... the Pharmaceutical Care Management Association (PCMA). Milliman projects that ... as 8.6 percent in 2015 as a result of ... The study finds that the majority of new ...
(Date:7/29/2014)... and NEW YORK , ... of the executive management team of Caremark Rx, ... Media ( www.pbm365.com ).  PBM365 is the leading independent ... reporting, insight, analysis and opinion on the pharmacy ... will provide insightful and timely coverage of, and context ...
Breaking Medicine Technology:EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Drew Crawford Announces Launch of PBM365 Media 2
... PALM BEACH, Fla., Dec. 15, 2011  China Nuvo Solar ... has recently conducted its first mobile product fair demonstration ... products.  The product fair was recently held and the ... and the Third-Party Consulting Company that has been contracted ...
... 2011  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... to its development pipeline, ISIS-APOARx, ISIS-DGAT2Rx and ISIS-FVIIRx.  Isis ... 12:00 p.m. Eastern Time to provide more detail on ... been an extremely successful year for Isis and positions ...
Cached Medicine Technology:China Nuvo Solar Energy, Inc./SurgLine Announces New Mobile Marketing Campaign 2Isis Adds Three New Drugs to Its Development Pipeline 2Isis Adds Three New Drugs to Its Development Pipeline 3Isis Adds Three New Drugs to Its Development Pipeline 4Isis Adds Three New Drugs to Its Development Pipeline 5
(Date:7/29/2014)... 29, 2014 (HealthDay News) -- Although the bite of ... heal well if left alone, an expert notes. ... an adverse reaction to a brown recluse spider bite, ... Poison Center, particularly since these potentially dangerous bites are ... for us to do nothing. The [bite] has classic ...
(Date:7/29/2014)... CarePoint Health is proud to ... network, CarePoint Health Medical Group. Our system welcomes ... of highly skilled and experienced physicians comprise CarePoint ... doctors and practices in Hudson County, representing a ... CarePoint Health’s commitment to provide the highest quality ...
(Date:7/29/2014)... Alan Mozes HealthDay Reporter ... autism patients with just a single dose of the hormone ... emotions, Japanese researchers report. Known as the "love hormone," ... bonding between lovers, and between mothers and their children. ... key area of the brain that has long been associated ...
(Date:7/29/2014)... Summer is here, and that means it’s time to ... in a pool or laying out on the beach. However, warm ... Puppy Store is here to help pet owners protect their dogs ... impossible to completely keep fleas and ticks at bay, but there ... their pets coming into contact with fleas and ticks. , Flea ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Bret ... LLP ’s Boise office, has been appointed to the ... Greater Idaho. , Busacker is an experienced business attorney ... matters. He advises clients on a wide spectrum of ... plan administration, compliance, and governance concerns. His clients include ...
Breaking Medicine News(10 mins):Health News:Brown Recluse Spider Bites on the Rise, Expert Warns 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 3Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:Protect Dogs From Fleas and Ticks During the Summer 2Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2
... monensin emerged in a project investigating the effects of ... prostate cancer cells. The project involved most of the ... amounts of compounds disulfiram (Antabus), thiram, tricostatin A, ... cancer cells without significant effects on the growth of ...
... , SATURDAY, Dec. 18 (HealthDay News) -- The hectic pace ... with chronic pain or other persistent health conditions to maintain ... risk for missed doses and even medication errors, according to ... can ensure safe and effective medication use over the holidays, ...
... future of cancer treatment and a University of Alberta graduate ... competitors from 80 of the best university graduate schools in ... of a light-sensitive drug to treat prostate cancer. ... research reviewed internally at the U of A and was ...
... Dec. 17 (HealthDay News) -- Among people with rheumatoid arthritis, ... is, even if they had been seeing one for quite ... people surveyed couldn,t decipher other medical words related to rheumatoid ... who conducted the survey noted that previous findings have suggested ...
... (HealthDay News) -- Differences in immune signaling pathways among ... than other primates to certain infectious diseases, researchers say. ... of HIV to AIDS or severe complications from hepatitis ... sensitive than chimpanzees to the serious effects of these ...
... perfect. It can indicate cancer when none is present and ... is more reliable in men taking dutasteride (Avodart), a drug ... lowers PSA levels by about half within six months. But ... levels among men taking the drug was a stronger indicator ...
Cached Medicine News:Health News:Finnish researchers find a compound that prevents the growth of prostate cancer cells 2Health News:Hectic Holiday Pace Can Upset Medication Schedule 2Health News:Master's student takes top thesis competition while tackling prostate cancer research 2Health News:Patient Literacy Problems Can Hinder Rheumatoid Arthritis Care 2Health News:Primate Immune System Differences Identified 2Health News:PSA test better predicts cancer in men taking prostate-shrinking drug 2Health News:PSA test better predicts cancer in men taking prostate-shrinking drug 3
The airlock allows anaerobic entry of large flasks, vessels, and up to 90 plates at a time....
Lose the variability of anaerobic jars and step into the 21st century with the anaerobic workstation that provides the answer to the common problems associated with anaerobic microbiology....
The 500 plate capacity MG-500 has an airlock for ease of use and an additional 100 plate capacity. Refrigeration is also available for growth of psychrophilic organisms...
... SATURN is adjustable in all directions by ... due to its simple, flexible handling. Alternatively, ... wired remote control or the operating panel ... and the seat section extension provide excellent ...
Medicine Products: